Anika Therapeutics reported $17.5M in Selling and Administration Expenses for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Selling And Administration Expenses Change
Abbott ABT:US $ 2.74B 14M
Acceleron Pharma XLRN:US $ 45.11M 9.64M
Acorda Therapeutics ACOR:US $ 29.62M 2.74M
Adamas Pharmaceuticals ADMS:US 29.73M 579K
Agenus AGEN:US $ 21.38M 4.73M
Agios Pharmaceuticals AGIO:US $ 27.15M 2.06M
Anika Therapeutics ANIK:US $ 17.5M 489K
Chemocentryx CCXI:US $ 19.6M 100K
Clovis Oncology CLVS:US $ 32.2M 722K
Dicerna Pharmaceuticals DRNA:US $ 21.99M 3.47M
Flexion Therapeutics FLXN:US $ 26.99M 423K
Halozyme Therapeutics HALO:US $ 13.17M 848K
Heron Therapeutics HRTX:US $ 34.99M 1.84M
Immunogen IMGN:US $ 10.3M 569K
Insmed INSM:US $ 60.28M 3.1M
Integra Lifesciences IART:US $ 149.62M 6.36M
Intrexon XON:US $ 18.66M 1.34M
Johnson & Johnson JNJ:US $ 6B 73M
Karyopharm Therapeutics KPTI:US $ 35.1M 1.43M
Ligand Pharmaceuticals LGND:US $ 12.72M 1.99M
Macrogenics MGNX:US $ 17.16M 1.93M
Merit Medical Systems MMSI:US $ 86.47M 5.09M
Rigel Pharmaceuticals RIGL:US $ 22.88M 499K
Sangamo Biosciences SGMO:US $ 14.5M 1.98M
Stryker SYK:US $ 1.42B 17M
Surmodics SRDX:US $ 7.86M 20K
Veracyte VCYT:US $ 59.54M 39.63M
Xencor XNCR:US $ 10.37M 1.51M
Zimmer Biomet Holdings Inc ZBH:US $ 802.4M 15M